Mechanism of Action: Chelating Activity
✉ Email this page to a colleague
Drugs with Mechanism of Action: Chelating Activity
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing | FOSCARNET SODIUM | foscarnet sodium | INJECTABLE;INJECTION | 213987-001 | Nov 29, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Avet Lifesciences | FOSCARNET SODIUM | foscarnet sodium | INJECTABLE;INJECTION | 213807-001 | Jun 5, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Gland Pharma Ltd | FOSCARNET SODIUM | foscarnet sodium | INJECTABLE;INJECTION | 213001-001 | Apr 21, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | FOSCARNET SODIUM | foscarnet sodium | INJECTABLE;INJECTION | 212483-001 | Jan 29, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Amneal | FOSCARNET SODIUM | foscarnet sodium | INJECTABLE;INJECTION | 216602-001 | Mar 1, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
